Budesonide inhalation suspension

DRUG3 trials

Sponsors

Allergan, AstraZeneca, Vanderbilt University

Conditions

Acute Chest SyndromeAsthmaSickle Cell Disease

Phase 1

Safety and Blood Level Study of Unit Dose Budesonide

CompletedNCT00627679

Start: 2005-12-31End: 2006-05-31Updated: 2014-01-09

Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial

CompletedNCT02187445

Vanderbilt UniversityAcute Chest Syndrome, Asthma, Sickle Cell Disease

Start: 2014-06-30End: 2017-02-13Updated: 2017-02-17

Phase 4

Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children

CompletedNCT00641472

AstraZenecaAsthma

Start: 2002-10-31End: 2005-02-28Target: 380Updated: 2009-03-25

Related Papers

Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.

2012-11-0814 citations